Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Free Radic Biol Med ; 29(2): 170-80, 2000 Jul 15.
Article in English | MEDLINE | ID: mdl-10980405

ABSTRACT

In this report we show that ubiquinone cytochrome c reductase (complex III) from isolated rat heart mitochondria when inhibited with antimycin A, produces a large amount of superoxide as measured by the chemiluminescent probe coelenterazine. When mitochondria are inhibited with myxothiazol or stigmatellin, there is no detectable formation of superoxide. The antimycin A-sensitive free radical production can be dramatically reduced using either myxothiazol or stigmatellin. This suggests that the antimycin A-sensitive generation of superoxides originates primarily from the Q(o) semiubiquinone. When manganese superoxide dismutase depleted submitochondrial particles (SMP) were inhibited with myxothiazol or stigmatellin, a large superoxide signal was observed. These two inhibitors likely increase the concentration of the Q(i) semiquinone at the N center. The antimycin A-sensitive signal can, in the case of both the mitochondria and the SMP, be dissipated by the addition of copper zinc superoxide dismutase, suggesting that the measured coelenterazine signal was a result of superoxide production. Taken together, this data suggests that free radicals generated from the Q(i) species are more effectively eliminated by MnSOD in intact mitochondria.


Subject(s)
Electron Transport Complex III/metabolism , Mitochondria, Heart/metabolism , Submitochondrial Particles/metabolism , Superoxide Dismutase/metabolism , Superoxides/metabolism , Animals , Antimycin A/pharmacology , Free Radicals/metabolism , Isoenzymes/metabolism , Kinetics , Methacrylates , Mitochondria, Heart/drug effects , Models, Chemical , Polyenes/pharmacology , Rats , Rats, Wistar , Submitochondrial Particles/drug effects , Thiazoles/pharmacology
2.
Hum Mutat ; 13(3): 245-54, 1999.
Article in English | MEDLINE | ID: mdl-10090480

ABSTRACT

Familial hypertrophic ventricular cardiomyopathy has been demonstrated to be associated with a number of mitochondrial DNA (mtDNA) mutations. A fibroblast cell line carrying a mutation in its mtDNA at position 9997 in the gene encoding tRNA glycine was obtained from a patient with hypertrophic cardiomyopathy. To demonstrate that the etiology of this disease was a result of the mtDNA mutation, cybrid clones were constructed by fusion of enucleated patient skin fibroblasts to rho0 osteosarcoma cells. Clones carrying high levels of mutant mtDNA showed predominantly cytochrome c oxidase and complex I deficiency, as well as an elevated lactate/pyruvate (L/P) ratio, a biochemical marker characteristic of respiratory chain deficiencies. Pulse-labeling experiments demonstrated a strong negative correlation between the levels of newly synthesized mtDNA-encoded polypeptides and glycine content. These data suggest that the T9997C mutation in mtDNA is causative of respiratory chain dysfunction when present at high levels of heteroplasmy.


Subject(s)
DNA, Mitochondrial/genetics , Electron Transport/physiology , Point Mutation , RNA, Transfer, Gly/genetics , Blotting, Southern , Cardiomyopathy, Hypertrophic/genetics , Citrate (si)-Synthase/metabolism , Electron Transport Complex II , Electron Transport Complex III/metabolism , Fibroblasts/enzymology , Fibroblasts/metabolism , Glycine/metabolism , Humans , Hybrid Cells , Lactic Acid/metabolism , Models, Genetic , Multienzyme Complexes/metabolism , NADH Dehydrogenase/metabolism , Oxidoreductases/metabolism , Phenotype , Pyruvic Acid/metabolism , Quinone Reductases/metabolism , Succinate Dehydrogenase/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...